ADVERTISEMENT

Transesophageal echocardiography to guide electrical cardioversion in atrial fibrillation

The ACUTE trial
Cleveland Clinic Journal of Medicine. 2002 September;69(9):713-718
September 1, 2002|Cleveland Clinic Journal of Medicine
Craig R. Asher, MD;Allan L. Klein, MD, FRCP(C), FACC, FAHA, FASE
Author and Disclosure Information

Craig R. Asher, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Allan L. Klein, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Allan L. Klein, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: kleina@ccf.org

ABSTRACTThe Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) trial compared cardioversion following transesophageal echocardiography (TEE) against conventional management of atrial fibrillation (ie, cardioversion following 3 weeks of anticoagulation) in patients scheduled to undergo electrical cardioversion.

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT